Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Tiollais

Showing results (131-140 of 193) with videos related to

Pageof 20
Sort By:
Oncogene|August 19, 2000
Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patientsA Marchio, P Pineau, M Meddeb, et al.
Journal of Virology|October 1, 1994
Vaccine-induced neutralizing antibodies directed in part to the simian immunodeficiency virus (SIV) V2 domain were unable to protect rhesus monkeys from SIV experimental challengeK Schlienger, D C Montefiori, M Mancini, et al.
Biochimie|January 1, 1978
Description and properties of bacteriophage lambda vectors useful for the cloning of EcoRI DNA fragmentsP Kourilsky, M Perricaudet, D Gros, et al.
Carcinogenesis|June 1, 1990
Transgenic mice containing hepatitis B virus sequences are more susceptible to carcinogen-induced hepatocarcinogenesisT A Dragani, G Manenti, H Farza, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1992
[Abnormal expression of hepatitis B virus sequences integrated in human hepatocellular carcinomas]B Terris, A Marchio, M G Mattei, et al.
Journal of Hepatology|July 14, 2001
Efficacy and limitations of a specific immunotherapy in chronic hepatitis BS Pol, B Nalpas, F Driss, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1992
Frequent amplification of c-myc in ground squirrel liver tumors associated with past or ongoing infection with a hepadnavirusC Transy, G Fourel, W S Robinson, et al.
Journal of Virology|December 1, 1996
The HNF1/HNF4-dependent We2 element of woodchuck hepatitis virus controls viral replication and can activate the N-myc2 promoterG Fourel, F Ringeisen, M Flajolet, et al.
Pathologie-Biologie|July 30, 2010
Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC): molecular mechanisms and novel paradigmsC Brechot, D Kremsdorf, P Soussan, et al.
The Journal of Infectious Diseases|June 3, 1999
Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigensI Couillin, S Pol, M Mancini, et al.
Pageof 20

Showing results (131-140 of 193) with videos related to

Sort By:
Pageof 20
Oncogene|August 19, 2000
Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patientsA Marchio, P Pineau, M Meddeb, et al.
Journal of Virology|October 1, 1994
Vaccine-induced neutralizing antibodies directed in part to the simian immunodeficiency virus (SIV) V2 domain were unable to protect rhesus monkeys from SIV experimental challengeK Schlienger, D C Montefiori, M Mancini, et al.
Biochimie|January 1, 1978
Description and properties of bacteriophage lambda vectors useful for the cloning of EcoRI DNA fragmentsP Kourilsky, M Perricaudet, D Gros, et al.
Carcinogenesis|June 1, 1990
Transgenic mice containing hepatitis B virus sequences are more susceptible to carcinogen-induced hepatocarcinogenesisT A Dragani, G Manenti, H Farza, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1992
[Abnormal expression of hepatitis B virus sequences integrated in human hepatocellular carcinomas]B Terris, A Marchio, M G Mattei, et al.
Journal of Hepatology|July 14, 2001
Efficacy and limitations of a specific immunotherapy in chronic hepatitis BS Pol, B Nalpas, F Driss, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1992
Frequent amplification of c-myc in ground squirrel liver tumors associated with past or ongoing infection with a hepadnavirusC Transy, G Fourel, W S Robinson, et al.
Journal of Virology|December 1, 1996
The HNF1/HNF4-dependent We2 element of woodchuck hepatitis virus controls viral replication and can activate the N-myc2 promoterG Fourel, F Ringeisen, M Flajolet, et al.
Pathologie-Biologie|July 30, 2010
Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC): molecular mechanisms and novel paradigmsC Brechot, D Kremsdorf, P Soussan, et al.
The Journal of Infectious Diseases|June 3, 1999
Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigensI Couillin, S Pol, M Mancini, et al.
Pageof 20